Blood test spots prostate cancer 15 years before symptoms
New blood tests can detect prostate cancer 15 years early and lung cancer traces before scans.
Summary
Researchers at Oxford University have developed a blood test that can identify men at risk of prostate cancer up to 15 years before symptoms appear, by analyzing proteins in the blood. Separately, a novel blood test, also known as a liquid biopsy, has been shown to reliably detect lingering lung cancer traces long before tumors are visible on scans, potentially predicting relapse risk and allowing for timely, personalized therapeutic interventions. This technology offers real-time genetic monitoring for lung cancer patients.
Why it's important
These advancements in blood testing offer the possibility of significantly earlier detection for two major cancers, potentially improving patient outcomes through preemptive or timely treatment interventions.
Key Points
- Prostate cancer early detection
- Lung cancer relapse prediction
- Blood test diagnostics
- Oxford University research
Key Narratives
Based on positions and claims visible in the cited sources. Missing viewpoints are not inferred as full national or institutional perspectives.
Researchers at Oxford University have developed a blood test capable of identifying men at risk of prostate cancer up to 15 years before symptoms manifest by analyzing proteins in the blood.
Involved Entities
Oxford University
Sources (2)
Blood test spots prostate cancer 15 years before symptoms
Oxford University researchers say analysis of proteins gives early warning for men most at risk
Novel blood test detects lung cancer traces long before scans
Despite advances in early-stage lung cancer treatment, a significant number of patients experience disease recurrence after surgery or initial therapy. A study has now demonstrated that a blood test (
Keep exploring this topic
Browse more stories in English or search Knewvia for a custom brief on any topic.